GI & Endoscopy

To combat its $30 billion debt, Lovell, Canada-based Valeant Pharmaceuticals is selling its Dendreon cancer business and three of its skincare brands for $2.12 billion.

Bitman Stewart, MD, is a gastroenterologist at Coral Springs, Fla.-based Digestive Care.

Santa Margarita, Calif.-based Integrated Endoscopy submitted a form D announcing a $4.4 million debt financing undertaking to compensate its executive officers throughout the year, Frisco Fastball reports.

Gastroenterologist Michael Newman, MD, is the new president of Melrose, Mass.-based Hallmark Health Medical Associates and system vice president of the Hallmark Health System, Wicked Local reports.

Madison, Wis.-based Exact Sciences — the makers of Cologuard — anticipates revenue between $34.9 and $25.4 million for the fourth quarter of fiscal year 2016.

Here are the top five most read Becker's ASC Review gastroenterology/endoscopy stories for the week of Jan. 2 to Jan. 6, 2017.

A study in Cancer investigated whether mammography and colonoscopy rates increased among fee-for-service Medicare beneficiaries following ACA implementation.

Paul Warfield, MD, is a gastroenterologist with Albuquerque, N.M.-based ABQ Health Partners.

Japan's Takeda Pharmaceuticals and San Diego's PvP Biologics are developing KumaMax, a novel enzyme that breaks down immune-reactive parts of gluten in the stomach, for patients with Celiac disease.

The American Academy of Pediatrics awarded the 2016 Murray Davidson Award to Steven M. Schwarz, MD.